Advertisement

Topics

BioGenesis InvestmentGroup, LLC Company Profile

01:50 EDT 20th September 2017 | BioPortfolio

BioGenesis Investment Group, LLC was originally formed to purchase technology and technology options and to develop these technologies through early development stages.Recently, BioGenesis Investment Group assisted with the transfer of a technology license from Mayo Clinic to Corus Pharma in Seattle, Washington.In 2001, BioGenesis Investment Group developed a technology valuation model for the biotech industry, which took into account the unique valuation nature of drugs in their development phase. Upon making this model public with the Nature Biotechnology Magazine article last September, the Red Herring Magazine article in March, 2002, and the various newspaper articles over the past few months, we received an overwhelming response from the Life Sciences and Finance industries.

Location

721 Lochsa St.
Suite 22
Post Falls
Idaho
83854
United States of America

Contact

Phone: 208-262-2062
Fax: 208-262-2063
Email: jozretich@bizjournals.com


News Articles [23 Associated News Articles listed on BioPortfolio]

ER-plasma membrane contact sites contribute to autophagosome biogenesis by regulation of local PI3P synthesis

The double-membrane-bound autophagosome is formed by the closure of a structure called the phagophore, origin of which is still unclear. The endoplasmic reticulum (ER) is clearly implicated in autopha...

A MILI-independent piRNA biogenesis pathway empowers partial germline reprogramming

MILI-mediated piRNA processing and amplification is not essential for all MIWI2 male germline reprogramming activity, indicating the existence of a MILI-independent piRNA biogenesis pathway.

Peroxisomal biogenesis disorder: New link to sugar metabolism

Peroxisomal biogenesis disorder, which has been linked only to lipid metabolism, is also associated with sugar metabolism.

Platelet BioGenesis raises $10M series A round

Qiming Invests in Boston Startup that Makes Platelets from Stem Cells

The Qiming US Healthcare Fund led a $10 million Series A funding of Platelet BioGenesis, a Boston startup developing a process to make platelets from stem cells. Platelets, which have a useful shelf l...

Atherosclerosis: Trehalose induces macrophage autophagy–lysosomal biogenesis

Molecular basis for the unusual ring reconstruction in fungal meroterpenoid biogenesis

Making the Rounds

Circular RNA biogenesis occurs when RNA fragments are bent into closed loops of one or more exons and/or introns.

Drugs and Medications [0 Results]

None

PubMed Articles [194 Associated PubMed Articles listed on BioPortfolio]

Organelle biogenesis in the endoplasmic reticulum.

Understanding organelle biogenesis is a central focus of cell biology. Whereas some are generated from existing organelles, others can be generated de novo. Most de novo organelle biogenesis occurs in...

Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans.

The induction of mitochondrial biogenesis could potentially alleviate mitochondrial and muscle disease. We show here that dimethyl fumarate (DMF) dose-dependently induces mitochondrial biogenesis and ...

Studying Factors Involved in Biogenesis of Lysobacter sp. XL1 Outer Membrane Vesicles.

The Gram-negative bacterium Lysobacter sp. XL1 produces outer membrane vesicles that are heterogeneous in size, density, and protein composition. One of the subpopulations is secretory vesicles for ly...

The Protein Phosphatase 4 and SMEK1 Complex Dephosphorylates HYL1 to Promote miRNA Biogenesis by Antagonizing the MAPK Cascade in Arabidopsis.

Phosphorylation plays an essential role in microRNA (miRNA) processing by regulating co-factors of the miRNA biogenesis machinery. HYL1 (Hyponastic Leaves 1), a core co-factor in plant miRNA biogenesi...

Regulation of Mitochondrial Complex I Biogenesis in Drosophila Flight Muscles.

The flight muscles of Drosophila are highly enriched with mitochondria, but the mechanism by which mitochondrial complex I (CI) is assembled in this tissue has not been described. We report the mechan...

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute Exercise

Objectives: The research focus of the study is the production of reactive oxygen species (ROS) in patients with type 2 diabetes (T2D) in response to glutathione (GSH) supplementation and i...

"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM

This study is designed to look at the effect of Pioglitazone treatment on the body's ability to burn food in order to produce energy.

Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm companies with the BCR-ABL fusion gene encoded by the Philadelphia (Ph) chromosome. The BCR-ABL fusion protein(the formation...

Risk Factors for Early Remodelling in Severe Asthma in Children

- Background: Asthma is a frequent disease characterized by bronchial hyperresponsiveness, inflammation and remodeling. Consistent epidemiological data indicate that outcome of ...

RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR

Mitochondrial myopathies are a multisystemic group of disorders that are characterized by a wide range of biochemical and genetic mitochondrial defects and variable modes of inheritance. ...

Companies [4 Associated Companies listed on BioPortfolio]

BioGenesis InvestmentGroup, LLC

BioGenesis Investment Group, LLC was originally formed to purchase technology and technology options and to develop these technologies through early development stages.Recently, BioGenesis Investment ...

Biogenesis Ltd

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers ar...

Biogenesis

Antibodies, Antigens, and other Immunoassy ReagentsContract manufacture of monoclonals, polyclonals, peptides.

MorphoSys AG

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next ge...

More Information about "BioGenesis InvestmentGroup, LLC" on BioPortfolio

We have published hundreds of BioGenesis InvestmentGroup, LLC news stories on BioPortfolio along with dozens of BioGenesis InvestmentGroup, LLC Clinical Trials and PubMed Articles about BioGenesis InvestmentGroup, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioGenesis InvestmentGroup, LLC Companies in our database. You can also find out about relevant BioGenesis InvestmentGroup, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record